Unveiling United Therapeutics (UTHR) Q4 Outlook: Wall Street Estimates for Key Metrics

Wall Street analysts forecast that United Therapeutics (UTHR) will report quarterly earnings of $6.78 per share in its upcoming release, pointing to a year-over-year increase of 9.5%. It is anticipated that revenues will amount to $805.31 million, exhibiting an increase of 9.4% compared to the year-ago quarter.The current level reflects a downward revision of 0.2% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reap ...